{
  "ticker": "HALO",
  "success": true,
  "price": {
    "current": 73.34,
    "currency": "USD",
    "day_high": 73.36,
    "day_low": 70.79,
    "52_week_high": 79.5,
    "52_week_low": 47.5
  },
  "market_cap": {
    "value": 8624563200.0,
    "currency": "USD"
  },
  "shares_outstanding": 117597000.0,
  "volume": {
    "last": 2061441,
    "average_30d": 1773255
  },
  "valuation": {
    "pe_ratio": 15.472574,
    "forward_pe": 8.979492,
    "price_to_book": 17.103544
  },
  "company_info": {
    "name": "Halozyme Therapeutics, Inc.",
    "sector": "Healthcare",
    "industry": "Biotechnology"
  },
  "balance_sheet": {
    "success": true,
    "period_date": "2025-09-30",
    "total_assets": 2221232000.0,
    "total_liabilities": 1717317000.0,
    "stockholders_equity": 503915000.0,
    "cash": 419665000.0,
    "marketable_securities": 282298000.0,
    "total_liquidity": 701963000.0,
    "total_debt": 1510757000.0,
    "long_term_debt": 800072000.0,
    "current_debt": 710685000.0,
    "error": null
  },
  "cash_flow": {
    "success": true,
    "period_date": "2025-09-30",
    "operating_cash_flow": 178597000.0,
    "free_cash_flow": 175567000.0,
    "investing_cash_flow": 201609000.0,
    "financing_cash_flow": -22402000.0,
    "error": null
  },
  "income_statement": {
    "success": true,
    "period_date": "2025-09-30",
    "operating_expense": 81101000.0,
    "research_and_development": 17251000.0,
    "interest_expense": 4296000.0,
    "net_income": 175225000.0,
    "revenue": 354264000.0,
    "gross_profit": 299022000.0,
    "ebitda": 243674000.0,
    "error": null
  },
  "data_quality": {
    "flags": [],
    "has_price": true,
    "has_market_cap": true,
    "has_volume": true,
    "has_balance_sheet": true,
    "has_cash_flow": true,
    "has_income_statement": true
  },
  "provenance": {
    "source": "Yahoo Finance via yfinance",
    "timestamp": "2026-01-29T16:47:48.920894",
    "url": "https://finance.yahoo.com/quote/HALO",
    "data_hash": "431c6dae433a994d"
  }
}